image
Healthcare - Biotechnology - NASDAQ - GB
$ 35.66
0.82 %
$ 2.92 B
Market Cap
-18.67
P/E
INCOME STATEMENT
0 REVENUE
0.00%
-67.8 M OPERATING INCOME
-2.59%
-54.6 M NET INCOME
20.55%
EFFICIENCY
Earnings Waterfall Verona Pharma plc
image
Revenue 0
Cost Of Revenue 680 K
Gross Profit -680 K
Operating Expenses 67.2 M
Operating Income -67.8 M
Other Expenses -13.3 M
Net Income -54.6 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005
REVENUE
Revenue 0 0.5 40.0 0 2.35 K 2.78 K 1.8 0 0 0 0 0 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 0.7 0.3 0 0.6 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit (0.7) 0.1 40.0 (0.6) (0.5) 2.78 K 1.8 0 0 0 0 0 0 0 0 0 0 0 0
OPERATING INCOME
Operating Expenses 67.2 66.2 97.7 66.0 53.4 32.5 40.2 8.5 13.3 5.9 4.6 4.2 2.9 2.9 2.6 2.2 2.6 1.3 12 K
Selling, General and Administrative Expenses 49.9 26.6 33.9 29.8 9.0 8.0 8.1 2.9 2.5 1.8 1.9 1.5 1.1 1.1 1.0 0.8 0.9 1.0 18.9 K
Research and Development Expenses 17.3 49.3 79.4 44.5 43.9 24.5 32.1 5.6 10.8 4.1 2.7 2.7 1.5 1.8 1.5 1.3 1.5 0.3 0
Operating Income (67.8) (66.1) (73.3) (74.3) (53.9) (32.5) (40.2) (8.7) (13.3) (5.9) (4.6) (4.2) (2.9) (2.9) (2.6) (2.2) (2.6) (1.3) 12 K
PRE-TAX INCOME
Interest Income Expense 2.1 0.5 0.3 35 K 0.2 0 98.7 K 0.1 0 0 0 0 0 0 0 0 0 0 0
Total Other Income 12.6 7.3 (1.4) 6.8 9.0 1.5 4.6 1.0 28 K 30 K 2.63 K 32.6 K 6.21 K 12.3 K 11.3 K 0.2 0.2 0.1 56.8 K
Pre-Tax Income (55.2) (68.4) (55.6) (65.0) (51.4) (30.6) (34.1) (7.4) (13.2) (5.9) (4.6) (4.1) (2.9) (2.9) (2.6) (2.0) (2.4) (1.2) 44.7 K
NET INCOME
Tax Provision (0.5) 0.3 18 K 0.1 (9.5) (5.4) (6.4) (1.2) (2.2) (1.6) (0.5) 77.7 K (0.2) 7.72 K 24.3 K 41 K 0.2 0.1 0
Net Income (54.4) (68.7) (55.6) (65.1) (41.9) (25.3) (27.7) (6.2) (11.0) (4.3) (4.2) (4.1) (2.7) (2.9) (2.6) (2.0) (2.4) (1.2) 44.7 K
EPS 0.54 1.04 0.94 1.98 3.18 0.19 0.25 0.003 0.0087 0.004 0.0098 0.0106 0.0088 0.0098 0.0096 0.0077 0.0134 0.0123 0.0008